Cannabidiol Market Key Players: ENDOCA, Cannoid, LLC, Folium Biosciences, And Elixinol

 Cannabidiol Industry Overview

The global cannabidiol market size was valued at USD 5.18 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 16.8% from 2022 to 2030. Cannabidiol is a chemical compound that is found in the cannabis sativa plant, and is extracted from hemp or cannabis, generally from hemp due to its naturally high cannabidiol (CBD) content. It has several benefits in treating anxiety and seizures and reducing pain. Due to its healing properties, the demand for CBD for health and wellness purposes is high, which is the major factor driving the market. In addition, the rising acceptance and use of products due to government approvals is a major factor expected to boost the production of CBD-infused products.

Cannabidiol oil is increasingly being used to make skincare products to treat acne and wrinkles. Sephora, for example, had recently introduced cannabidiol or CBD skincare line to its stores. Similarly, Ulta Beauty is intending to launch a cannabidiol-based product line. Several new companies are also entering the market for cannabidiol-infused cosmetic products. For instance, in 2019, Aphria, a producer and distributor of medicinal and recreational cannabis-based in Canada, introduced its Cannabidiol-based cosmetics line in Germany. 

 

Gather more insights about the market drivers, restrains and growth of the Global Cannabidiol market

 

However, the COVID-19 pandemic has caused unprecedented lockdowns all around the world, collapsing daily operations and changing consumer behaviors in nearly every industry. As the response to COVID-19 ramps up, retail stores have shut down. The market started witnessing a shortage in supply due to the nationwide shutdown of transportation and manufacturing in major raw material manufacturing countries, such as China and India. In addition, due to supply chain disruptions in the U.S., the supply of other raw materials has been limited, which is disrupting the manufacturing, and in turn, the supply chain of CBD consumer health products. 

Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such as anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and inflammation. Due to the increasing adoption of CBD-based products to treat ailments, the global market is anticipated to grow at a lucrative rate over the forecast period.

Furthermore, the government of different countries as well as major players in the cannabinoid market are investing in research and development activities. The CBD is said to be an effective treatment for various neurological diseases including epilepsy in several clinical trials. Players like Echo Pharmaceuticals developed a product called Arvisol, which is an oral tablet containing pure cannabinoids, for treatment including epilepsy and schizophrenia. Zynerba Pharmaceutical, for instance, developed a cannabinoid-based gel named Zygel, designed for treating Fragile X syndrome, encephalopathies, and adult seizures.

Increasing awareness regarding cannabidiol's therapeutic benefits has influenced buyers to buy cannabidiol products, regardless of their cost. As these have a greater profit margin, commercial retailers are now focusing on selling cannabis-based products. Numerous health and wellness retailers are offering CBD-based products, such as Rite Aid, CVS Health, and Walgreens Boots Alliance. In addition, CVS Health decides to offer CBD topicals all over its 800 stores and Walgreens Boots Alliance is selling CBD-containing topicals across 1500 of its stores in the U.S.

On the other hand, the existence of strict regulations and the high cost of cannabidiol products are some of the major factors limiting the growth of the market. In addition, the absence of legalization initiatives in many Asian and African countries is another main factor impeding market growth. Additionally, due to the increased adoption for a wide range of medical conditions, cannabidiol-based products have gained traction in recent years. This has opened the door for illegal manufacturers to create synthetic medicines that do not include cannabidiol but do contain chemical compounds that have similar benefits to cannabidiol but are also harmful to the body. These unauthorized products are less expensive than the originals and claim to have a higher concentration of Cannabidiol, which may be used to treat a variety of health issues. For instance, as of February 2020, around 68 people died due to the consumption of synthetic cannabis in the U.S. with more than 2800 patients hospitalized due to vaping, e-cigarette, and use-associated lung injury. This is restricting the demand for the market.


Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

  • Alopecia Market - The global alopecia market size was valued at USD 7.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% from 2021 to 2028. The increasing prevalence of hair loss, technological advancements in alopecia treatment, and the rise in prevalence of chronic diseases that are associated with hair loss are some of the major factors driving the market.

  • Tunisia Pharmaceutical Market - The Tunisia pharmaceutical market size was estimated at USD 1.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 12.9% from 2021 to 2028. The market is driven by the presence of various developed and integrated facilities that promote R&D, production of pharmaceuticals in the country.


Cannabidiol Market Segmentation

Grand View Research has segmented the global cannabidiol market based on source type, distribution channel, end-use, and region:

Cannabidiol Source Type Outlook (Revenue, USD Million, 2017 - 2030)

  • Hemp
  • Marijuana

Cannabidiol Sales Type Outlook (Revenue, USD Million, 2017 - 2030)

  • B2B
  • B2C

Cannabidiol End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Medical
  • Personal Use
  • Pharmaceuticals
  • Wellness

CBD Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 


Market Share Insights

  • January 2021: Nano Hydrate has introduced product marketing services that use innovative technologies to promote natural treatment through pharmaceutical-grade cannabidiol branding services.

 

Key Companies profiled:

Some prominent players in the global cannabidiol market include:

  • ENDOCA
  • Cannoid, LLC
  • Medical Marijuana, Inc.
  • Folium Biosciences
  • Elixinol
  • NuLeaf Naturals, LLC
  • Isodiol International, Inc.
  • Pharmahemp d.o.o. 


Order a free sample PDF of the Cannabidiol Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

 

Comments

Post a Comment

Popular posts from this blog

Breast Pump and Breastfeeding Accessories Market Updates and Projections

  Breast Pump And Breastfeeding Accessories Industry Data Book | Forecast 2030 Breast Pump And Breastfeeding Accessories Industry Data Book - Breast Pump, Wearable Breast Pump & Breastfeeding Accessories Market Grand View Research’s breast pump & breastfeeding accessories industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.   Access the Global Breast Pump And Breastfeeding Accessories Industry Data Book, 2023 to 2030 , compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory ...
Read more

Spectrometry Sector: Emerging Technologies 2023-2030

  Spectrometry Industry | Forecast 2030 Spectrometry industry data book is a combination of the market data from five reports namely, spectrometry, mass spectrometry, NMR spectroscopy, near-infrared spectroscopy, and in-line UV-vis spectroscopy market. The market was valued at USD 17.4 billion in 2021 with a CAGR of 7.34% during 2022-2030. NMR spectroscopy market and Near-infrared Spectroscopy market are also growing at the CAGR of 5.1% and 6.08% respectively. The development of advanced spectrometry instruments and consumables is anticipated to create growth opportunities in this market and drive the market in the coming years.   Access the Global Spectrometry Industry Data Book, 2024 to 2030 , compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies   Spectrometry holds significant potential in the near future o...
Read more

Endoscopy Devices Market Predicted to Witness Strong Growth from 2023 to 2030

  Endoscopy Devices Industry | Forecast 2030 The global endoscopy devices market was valued at USD 50.8 Billion in 2022 and is anticipated to grow at a CAGR of 7.5% over the forecast period. The market growth is attributed to the presence of cost-effective pre and post-procedures and increasing awareness regarding the minimal invasive properties of the devices. COVID-19 has impacted the market negatively as the number of endoscopic procedures reduced owing to the postponed and canceled elective and semi-urgent procedures. However, the increasing geriatric population, coupled with the rising burden of chronic diseases, is anticipated to drive the market. Furthermore, increasing the preference for disposable endoscopic equipment reduce the possibility of cross-contamination is anticipated to drive the market over the forecast period.   Access the Global Endoscopy Devices Industry Data Book, 2023 to 2030 , compiled with details like market sizing information & forecasts, ...
Read more